This call is focused on antimicrobial treatments and therapeutic protocol adherence—a biomedical and pharmaceutical domain entirely outside Acme Corporation's semiconductor and AI expertise. There is no meaningful match between the call's health/pharma objectives and the client's stated strategic priorities in semiconductors, AI, photonics, or space/defence.
Alors que la résistance aux antibiotiques serait responsable de la mort de 1.27 millions de personnes en 2019 (Murray et al., 2022) et que la résistance aux fongicides gagne du terrain, il est désormais urgent d’agir sans attendre. Sans actions de prévention efficaces, et sans nouveaux traitements o